Brokerages Expect Molina Healthcare, Inc. (NYSE:MOH) Will Post Quarterly Sales of $4.08 Billion

Wall Street brokerages predict that Molina Healthcare, Inc. (NYSE:MOH) will report sales of $4.08 billion for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Molina Healthcare’s earnings, with the lowest sales estimate coming in at $4.03 billion and the highest estimate coming in at $4.16 billion. Molina Healthcare reported sales of $4.88 billion in the same quarter last year, which indicates a negative year over year growth rate of 16.4%. The company is scheduled to report its next quarterly earnings results on Tuesday, July 30th.

On average, analysts expect that Molina Healthcare will report full-year sales of $16.39 billion for the current fiscal year, with estimates ranging from $16.27 billion to $16.45 billion. For the next financial year, analysts expect that the business will report sales of $17.77 billion, with estimates ranging from $17.40 billion to $18.08 billion. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Molina Healthcare.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Monday, April 29th. The company reported $3.04 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.41 by $0.63. Molina Healthcare had a net margin of 4.35% and a return on equity of 49.21%. The business had revenue of $4.12 billion for the quarter, compared to the consensus estimate of $4.07 billion. During the same period in the prior year, the company posted $1.26 earnings per share. Molina Healthcare’s revenue was down 11.3% compared to the same quarter last year.

MOH has been the topic of several research reports. Barclays restated a “hold” rating and issued a $140.00 price target on shares of Molina Healthcare in a research note on Sunday, May 5th. Cowen initiated coverage on shares of Molina Healthcare in a research note on Thursday, February 28th. They issued a “market perform” rating on the stock. BMO Capital Markets upgraded shares of Molina Healthcare from a “market perform” rating to an “outperform” rating and upped their price target for the company from $154.00 to $200.00 in a research note on Monday, June 3rd. Wells Fargo & Co upgraded shares of Molina Healthcare from a “market perform” rating to an “outperform” rating and set a $177.00 price target on the stock in a research note on Friday, May 31st. Finally, Bank of America restated an “underperform” rating and issued a $132.00 price target (up from $129.00) on shares of Molina Healthcare in a research note on Tuesday, April 30th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $160.92.

MOH stock opened at $141.34 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.57 and a quick ratio of 1.57. The company has a 50-day simple moving average of $140.25. Molina Healthcare has a 52 week low of $96.74 and a 52 week high of $159.00. The firm has a market capitalization of $9.10 billion, a P/E ratio of 12.76, a PEG ratio of 1.01 and a beta of 1.37.

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $126.30, for a total transaction of $126,300.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Garrey Carruthers sold 1,300 shares of the stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $152.75, for a total transaction of $198,575.00. The disclosure for this sale can be found here. Insiders have sold 6,304 shares of company stock worth $945,495 over the last quarter. Corporate insiders own 0.77% of the company’s stock.

Several hedge funds have recently bought and sold shares of the company. Parallel Advisors LLC lifted its holdings in shares of Molina Healthcare by 97.9% in the first quarter. Parallel Advisors LLC now owns 186 shares of the company’s stock worth $26,000 after acquiring an additional 92 shares during the last quarter. Cornerstone Advisors Inc. lifted its holdings in shares of Molina Healthcare by 3,577.8% in the first quarter. Cornerstone Advisors Inc. now owns 331 shares of the company’s stock worth $47,000 after acquiring an additional 322 shares during the last quarter. FTB Advisors Inc. lifted its holdings in shares of Molina Healthcare by 367.6% in the first quarter. FTB Advisors Inc. now owns 346 shares of the company’s stock worth $48,000 after acquiring an additional 272 shares during the last quarter. Financial Gravity Wealth Inc. bought a new position in shares of Molina Healthcare in the first quarter worth about $54,000. Finally, Quadrant Capital Group LLC lifted its holdings in shares of Molina Healthcare by 289.3% in the first quarter. Quadrant Capital Group LLC now owns 545 shares of the company’s stock worth $71,000 after acquiring an additional 405 shares during the last quarter.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Featured Article: What is meant by buying and selling pressure?

Get a free copy of the Zacks research report on Molina Healthcare (MOH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.